Skip to main content

Greedy Insider

SRTA Insider Trades and Greediness Scores

Strata Critical Medical, Inc. (SRTA) insider trades: since Dec 5, 2025, Greedy Insider recorded 2 open-market buys and 31 sales on Form 4 from 7 insiders. The strongest recent filing scored 87 (Strong).

Who bought and who sold

Across the last 33 scoreable Form 4 transactions in SRTA, 2 were open-market purchases and 31 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.

InsiderRoleTypeSharesDateScore
Tomkiel Melissa M.Co-CEO and General CounselSell90797.0478500.22026-09-2471View
Heyburn William A.Co-CEO and CFOSell98356.0518336.122026-09-2473View
Verdetto Louis R.CEO, Clinical ServicesSell5697.030251.072026-09-0882View
Wunsch Scott MCEO, LogisticsSell5711.030325.412026-09-0878View
Cohen AmirChief Accounting OfficerSell4645.024664.952026-09-0872View
Tomkiel Melissa M.Co-CEO and General CounselSell29730.0157866.32026-09-0873View
Heyburn William A.Co-CEO and CFOSell31671.0168173.022026-09-0874View
Love ReginaldDirectorSell5091.029273.252026-08-1066View
Cohen AmirChief Accounting OfficerSell34015.0173136.342026-07-3183View
Heyburn William A.Co-CEO and CFOSell199209.01013973.82026-07-3184View

The strongest recent filing

Heyburn William A. (Co-CEO and CFO) sold 301,731 shares of Strata Critical Medical, Inc. on Apr 24, 2026, a filing that scored 87 (Strong). It scored Strong because a senior insider was trading and it was direct personal ownership. The score describes the filing, not future returns. This is not investment advice.

Cluster activity

A cluster buy is present: 4 insiders (Cohen Amir, Heyburn William A., Wunsch Scott M, Tomkiel Melissa M.) traded SRTA the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.

How this compares with Strata Critical Medical, Inc.'s own history

Open-market buys make up 6% of the 33 scoreable SRTA transactions on record between Dec 5, 2025 and Sep 24, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.

Methodology and sources

Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.

Key facts

  • Scoreable Form 4 transactions on record: 33
  • Open-market buys: 2
  • Sales: 31
  • Distinct insiders: 7
  • Strongest recent Greediness Score: 87 (Strong)

Primary sources

Related

The score describes the filing, not future returns. This is not investment advice.